Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease

European Journal of Human Genetics

Volumn 17, Issue 3, 2009, Pages 368-377

  FitzGerald, Liesel M ^a   Patterson, Briony ^a   Thomson, Russell ^a   Polanowski, Andrea ^a   Quinn, Stephen ^a   Brohede, Jesper ^b   Thornton, Timothy ^c   Challis, David ^d   Mackey, David A ^a,e,f   Dwyer, Terence ^a,g   Foote, Simon ^a   Hannan, Garry N ^h   Stankovich, James ^a,i   McKay, James D ^a,j   Dickinson, Joanne L ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ROYAL HOBART HOSPITAL   (Australia)

^e ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^h CSIRO   (Australia)

ⁱ WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^j INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 5P; CONTROLLED STUDY; FAMILIAL CANCER; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE; SINGLE NUCLEOTIDE POLYMORPHISM;

CHROMOSOMES, HUMAN, PAIR 5; FAMILY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PEDIGREE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 60749132520     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.171     Document Type: Article

References (41)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-543.
2. Gronberg H, Damber L, Damber JE, Iselius L: Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance. Am J Epidemiol 1997; 146: 552-557.
3. Schaid DJ, McDonnell SK, Blute ML, Thibodeau SN: Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998; 62: 1425-1438.
4. Xu J, Dimitrov L, Chang BL et al: A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005; 77: 219-229.
5. Wildund F. Gillanders EM, Albertus JA et al: Genome-wide scan of Swedish families with hereditary prostate cancer: Suggestive evidence of linkage at 5q11.2 and 19p13.3. Prostate 2003; 57: 290-297.
6. Amundadottir LT, Sulem P, Gudmundsson J et al: A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38: 652-658.
7. Gudmundsson J, Sulem P, Manolescu A et al: Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39: 631-637.
8. Haiman CA, Patterson N, Freedman ML et al: Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007; 39: 638-644.
9. Yeager M, Orr N, Hayes RB et al: Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645-649.
10. Eeles RA, Kote-Jarai Z, Giles GG et al: Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008, 40: 316-321.
11. Gudmundsson J, Sulem, P, Rafnar T et al: Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008; 40: 281-283.
12. Thomas G, Jacobs KB, Yeager M et al: Multiple loci identifted in a genome-wide association study of prostate cancer. Nat Genet 2008; 40: 310-315.
13. Risch N: The genetic epidemiolIgy of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001; 10: 733-741.
14. Wang WY, Barratt BJ, Clayton DG, Todd JA: Genome-wide association studies: Theoretical and practical concerns. Nat Rev Genet 2005; 6: 109-118.
15. Smith JR, Freije D, Carpten JD et al: Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996; 274: 1371-1374.
16. Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM: Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001; 68: 1197-1206.
17. Hsieh CL, Oakley-Girvan I, Balise RR et al: A genome screen of families with multiple cases of prostate cancer: Evidence of genetic heterogeneity. Am J Hum Genet 2001; 69: 148-158.
18. Slager SL, Zarfas KE, Brown WM et al: Genome-wide linkage scan for prostate cancer aggresiveness loci using families from the University of Michigan Prostate Cancer Genetics Project. Prostate 2006; 66 173-179.
19. Sato Y, Sugie R, Tsuchiya B, Kameya T, Natori M, Mukai K: Comparison of the DNA extraction methods for polymerase chain reaction amplification from formalin-fixed and paraffin-embedded tissues. Diagn Mol Pathol 2001; 10: 265-271.
20. Kennedy GC, Matsuzaki H, Dong S et al: Large-scale genotyping of complex DNA. Nat Biotechnol 2003; 21: 1233-1237.
21. O'CoAnell JR, Weeks DE: PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
22. Abecasis GR, Cherny SS, Cookson WO, Cardon LR: Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97-101.
23. Sobel E, Lange K: Descent graphA in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 1996, 58: 1323-1337.
24. Thomson R, Quinn S, McKay J et al: The advantages of dense marker sets for linkage analysis with very large families. Hum Genet 2007; 121: 459-468.
25. Lander E, Kruglyak L: Genetic diGsection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
26. Thornton T, McPeek MS: Case-control association testing with related individuals: A more powerful quasi-likelihood score test. Am J Hum Genet 2007; 81: 321-337.
27. Jacquelin B, Tarantino MD, Kritzik M et al: Allele-dependent transcriptional regulation of the human integrin alpha2 gene. Blood 2001; 97: 1721-1726.
28. Kunicki TJ: The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 2002; 22: 14-20.
29. Koistinen P. Heino J: Integrins in Cancer Cell Invasion; in Heino J (ed): Cancer Invasion. Austin, USA, 2006, Vol. 19. Available online at: http://www.landesbioscience.com
30. Knox JD, Cress AE, Clark V et al: Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol 1994; 145: 167-174.
31. Knudsen BS, Miranti CK: The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression. J Cell Biochem 2006; 99: 345-361.
32. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951.
33. Bonkhoff H, Stein U, Remberger K: Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: Simultaneous demonstration of cell surface receptors and their extracellular ligands. Hum Pathol 1993; 24 243-248.
34. Langsenlehner U, Renner W, Yazdani-Biuld B et al: Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk. Breast Cancer Res Treat 2006; 97: 67-72.
35. Vairaktaris E, Yapijakis C, Derka S et al: Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer. Eur J Surg Oncol 2006; 32: 455-457.
36. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ: Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence. Blood 1997; 89: 1939-1943.
37. Camp NJ, Tavtigian SV. Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. Am J Hum Genet 2002; 71: 1475-1478.
38. Severi G, Giles GG, Southey MC et al: EIAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. J Natl Cancer Inst 2003; 95: 818-824.
39. Sun J, Hsu FC, Turner AR et al: Meta-analysis of association of rare mutations and common sequence vanants in the MSR1 gene and prostate cancer risk. Prostate 2006; 66: 728-737.
40. Nupponen NN, Wallen MJ, Ponciano D et al: Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer. Genes Chromosomes Cancer 2004; 39: 119-125.
41. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994; 265: 2037-2048.